Koulu M - Search Results

1

Reduced turnover of dopamine and 5-hydroxytryptamine in discrete dopaminergic, noradrenergic and serotonergic rat brain areas after acutely administered medetomidine, a selective alpha 2-adrenoceptor agonist.

Koulu M, Pesonen U, Koskinen S, Scheinin H, Virtanen R, Scheinin M. Koulu M, et al. Pharmacol Toxicol. 1993 Mar;72(3):182-7. doi: 10.1111/j.1600-0773.1993.tb00313.x. Pharmacol Toxicol. 1993. PMID: 8100065

2

Sedative and cardiovascular effects of medetomidine, a novel selective alpha 2-adrenoceptor agonist, in healthy volunteers.

Scheinin M, Kallio A, Koulu M, Viikari J, Scheinin H. Scheinin M, et al. Among authors: koulu m. Br J Clin Pharmacol. 1987 Oct;24(4):443-51. doi: 10.1111/j.1365-2125.1987.tb03196.x. Br J Clin Pharmacol. 1987. PMID: 2891369 Free PMC article. Clinical Trial.

3

Acute effects of medetomidine, a selective alpha 2-adrenoceptor agonist, on anterior pituitary hormone and cortisol secretion in man.

Kallio A, Koulu M, Scheinin H, Viikari J, Scheinin M. Kallio A, et al. Among authors: koulu m. Acta Endocrinol (Copenh). 1988 Sep;119(1):11-5. doi: 10.1530/acta.0.1190011. Acta Endocrinol (Copenh). 1988. PMID: 2901180 Clinical Trial.

4

Alpha 2-adrenoceptor density in forebrain areas of Zucker rats: no effect of genetic obesity or antiglucocorticoid treatment.

Pesonen U, Miettinen T, Scheinin M, Koulu M. Pesonen U, et al. Among authors: koulu m. Brain Res. 1992 Mar 6;574(1-2):353-6. doi: 10.1016/0006-8993(92)90841-v. Brain Res. 1992. PMID: 1322226

5

Chronic dexmedetomidine, a selective alpha 2-agonist, decreases serotonin but not noradrenaline turnover in rat brainstem nuclei.

Koulu M, Pesonen U, Virtanen R. Koulu M, et al. Eur J Pharmacol. 1990 Feb 6;176(2):151-7. doi: 10.1016/0014-2999(90)90523-9. Eur J Pharmacol. 1990. PMID: 1690141

6

No involvement of alpha 2-adrenoceptors in the regulation of basal prolactin secretion in healthy men.

Karhuvaara S, Kallio A, Koulu M, Scheinin H, Scheinin M. Karhuvaara S, et al. Among authors: koulu m. Psychoneuroendocrinology. 1990;15(2):125-9. doi: 10.1016/0306-4530(90)90020-a. Psychoneuroendocrinology. 1990. PMID: 1972797 Clinical Trial.

7

Effects of acute GR38032F (odansetron), a 5-HT3 receptor antagonist, on dopamine and serotonin metabolism in mesolimbic and nigrostriatal dopaminergic neurons.

Koulu M, Sjöholm B, Lappalainen J, Virtanen R. Koulu M, et al. Eur J Pharmacol. 1989 Oct 10;169(2-3):321-4. doi: 10.1016/0014-2999(89)90031-9. Eur J Pharmacol. 1989. PMID: 2530097

8

Effects of dexmedetomidine, a selective alpha 2-adrenoceptor agonist, on hemodynamic control mechanisms.

Kallio A, Scheinin M, Koulu M, Ponkilainen R, Ruskoaho H, Viinamäki O, Scheinin H. Kallio A, et al. Among authors: koulu m. Clin Pharmacol Ther. 1989 Jul;46(1):33-42. doi: 10.1038/clpt.1989.103. Clin Pharmacol Ther. 1989. PMID: 2568211 Clinical Trial.

9

Chronic treatment with SCH 23390, a selective dopamine D-1 receptor antagonist, decreases dopamine metabolism in rat caudate nucleus.

Koulu M, Lappalainen J, Pesonen U, Hietala J, Syvälahti E. Koulu M, et al. Eur J Pharmacol. 1988 Oct 18;155(3):313-6. doi: 10.1016/0014-2999(88)90521-3. Eur J Pharmacol. 1988. PMID: 3069483

10

Potentiation of the anti-obesity effect of the selective beta 3-adrenoceptor agonist BRL 35135 in obese Zucker rats by exercise.

Santti E, Huupponen R, Rouru J, Hänninen V, Pesonen U, Jhanwar-Uniyal M, Koulu M. Santti E, et al. Among authors: koulu m. Br J Pharmacol. 1994 Dec;113(4):1231-6. doi: 10.1111/j.1476-5381.1994.tb17129.x. Br J Pharmacol. 1994. PMID: 7889277 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

129 results

Search Page

Filters